Stockscreener 앱 받기
0.9589
0.80%
0.0161
전일 마감가:
$0.9428
열려 있는:
$0.9459
하루 거래량:
107.26K
Relative Volume:
0.42
시가총액:
$60.67M
수익:
$3.67M
순이익/손실:
$-13.83M
주가수익비율:
-3.4245
EPS:
-0.28
순현금흐름:
$-10.79M
1주 성능:
-7.74%
1개월 성능:
-8.62%
6개월 성능:
-17.72%
1년 성능:
+20.44%
1일 변동 폭
$0.9459
$0.98
1주일 범위
$0.9425
$1.03
52주 변동 폭
$0.48
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
ICCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.9502 | 60.67M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
133.02 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
101.92 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
375.01 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.72 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.95 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Icecure Medical Ltd 주식(ICCM)의 최신 뉴스
Cryoablation Probe Market Size, Share | Industry Report 2030 - Grand View Research
IceCure Medical takes another step towards a full patent application in US - Mugglehead Magazine
IceCure Medical (ICCM) Secures U.S. Patent for Cryogen Flow Cont - GuruFocus
IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes - GuruFocus
IceCure Medical (ICCM) Secures U.S. Patent for Cryogen Flow Control | ICCM Stock News - GuruFocus
IceCure Receives Notice of Patent Allowance in U.S. for a Novel - GuruFocus
IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes | ICCM Stock News - GuruFocus
H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 - Investing.com Australia
IceCure Medical’s (ICCM) Buy Rating Reaffirmed at HC Wainwright - Defense World
Icecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Strategic Advances and Market ... - Yahoo Finance
Icecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Strategic Advances and Market Challenges - GuruFocus
Icecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Str - GuruFocus
ICCM: HC Wainwright & Co. Reiterates Buy Rating with $2.50 Price Target | ICCM Stock News - GuruFocus
IceCure Medical Ltd (NASDAQ:ICCM) Q1 2025 Earnings Call Transcript - Insider Monkey
IceCure Medical outlines post-market study plan for ProSense amid FDA engagement and prepares for US commercial launch - MSN
IceCure Medical reports 2% revenue drop in Q1 2025 - Medical Buyer
IceCure Medical Reports Q1 2025 Financial Results - TipRanks
IceCure Medical’s Earnings Call: Optimism Amid Challenges - TipRanks
Transcript : IceCure Medical Ltd, Q1 2025 Earnings Call, May 28, 2025 - marketscreener.com
Icecure Medical Ltd reports results for the quarter ended March 31Earnings Summary - TradingView
IceCure (ICCM) Q1 2025 Earnings Call Transcript - The Globe and Mail
IceCure (ICCM) Q1 2025 Earnings Call Transcript - The Motley Fool
IceCure Medical Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
ICECURE MEDICAL Earnings Results: $ICCM Reports Quarterly Earnings - Nasdaq
IceCure Medical Reports First Quarter 2025 Financial Results - PR Newswire
Icecure Medical Ltd (ICCM) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025 - Nasdaq
IceCure Medical Secures $2 Million Bridge Loan from Epoch - TipRanks
IceCure Medical (ICCM) Expected to Announce Earnings on Tuesday - Defense World
IceCure Medical’s Shareholders Approve Key Agenda Items at Special Meeting - TipRanks
Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders - marketscreener.com
FY2025 EPS Estimates for IceCure Medical Boosted by Analyst - Defense World
IceCure Receives High Level of Interest from Breast Surgeons at - GuruFocus
IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation - PR Newswire
IceCure Medical Ltd (NASDAQ:ICCM) Shares Acquired by Geode Capital Management LLC - Defense World
IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America - Barchart.com
IceCure Medical reports on FDA meeting for ProSense Cryoablation - TipRanks
ICCM Advances ProSense Approval with FDA Interface | ICCM Stock News - GuruFocus
IceCure Announces Positive FDA Development: Understanding on Pat - GuruFocus
IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer - PR Newswire
IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium - GuruFocus
IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems - marketscreener.com
Comparing Biotricity (NASDAQ:BTCY) and IceCure Medical (NASDAQ:ICCM) - Defense World
IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation - StreetInsider
IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation | ICCM Stock News - GuruFocus
Icecure Medical Ltd (ICCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.01%
0.25%
자본화:
|
볼륨(24시간):